Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;9(1):2406.
doi: 10.1186/1556-276X-9-684. Epub 2014 Dec 18.

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles

Affiliations

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles

Linghui Dian et al. Nanoscale Res Lett. 2014 Dec.

Abstract

To improve its poor aqueous solubility and stability, the potential chemotherapeutic drug quercetin was encapsulated in soluplus polymeric micelles by a modified film dispersion method. With the encapsulation efficiency over 90%, the quercetin-loaded polymeric micelles (Qu-PMs) with drug loading of 6.7% had a narrow size distribution around mean size of 79.00 ± 2.24 nm, suggesting the complete dispersibility of quercetin in water. X-ray diffraction (XRD) patterns illustrated that quercetin was in amorphous or molecular form within PMs. Fourier transform infrared spectroscopy (FTIR) indicated that quercetin formed intermolecular hydrogen bonding with carriers. An in vitro dialysis test showed the Qu-PMs possessed significant sustained-release property, and the formulation was stable for at least 6 months under accelerated conditions. The pharmacokinetic study in beagle dogs showed that absorption of quercetin after oral administration of Qu-PMs was improved significantly, with a half-life 2.19-fold longer and a relative oral bioavailability of 286% as compared to free quercetin. Therefore, these novel soluplus polymeric micelles can be applied to encapsulate various poorly water-soluble drugs towards a development of more applicable therapeutic formulations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The structure of quercetin (A), soluplus (B) and formation of PMs (C).
Figure 2
Figure 2
Effects of stabilizer F 127 concentration on size and EE of Qu-PMs ( n= 3).
Figure 3
Figure 3
Effect of magnetic stirring time on size and encapsulation efficiency ( n= 3).
Figure 4
Figure 4
Size (A), zeta potential (B), TEM (C), and colloidal solution (D) of Qu-PMs.
Figure 5
Figure 5
XRD of Qu (a), physical mixture (b), Qu-PMs (c), and void PMs (d).
Figure 6
Figure 6
FTIR of Qu (a), physical mixture (b), void PMs (c), and Qu-PMs (d).
Figure 7
Figure 7
Release of quercetin from propylene glycol solution and Qu-PMs suspension.
Figure 8
Figure 8
Mean quercetin plasma concentration.

References

    1. Lavellea EC, Sharif S, Thomas NW, Holland J, Davis SS. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv Drug Delivery Rev. 1995;18:5–22. doi: 10.1016/0169-409X(95)00048-C. - DOI
    1. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996;22:531–539. doi: 10.3109/03639049609108355. - DOI
    1. Dian LH, Yang ZW, Li F, Wang ZH, Pan X, Peng XS, Huang XT, Guo ZF, Quan GL, Shi X, Chen B, Li G, Wu CB. Cubic phase nanoparticles for sustained release of ibuprofen: Formulation, characterization and enhanced bioavailability study. Int J Nanomedicine. 2013;8:845–854. - PMC - PubMed
    1. Johnston APR, Such GK, Ng SL, Caruso F. Challenges facing colloidal delivery systems: FROM synthesis to the clinic. Curr Opin Colloid Interface Sci. 2011;16:171–181. doi: 10.1016/j.cocis.2010.11.003. - DOI
    1. Bromberg L. Polymeric micelles in oral chemotherapy. J Control Release. 2008;128:89–112. doi: 10.1016/j.jconrel.2008.01.018. - DOI - PubMed